VIRGINIA KAKLAMANI (@VKaklamani) profile picture

VIRGINIA KAKLAMANI

@VKaklamani

Oncologist and tennis player

Joined November 2020
  • Tweets541
  • Following155
  • Followers1.9K
147Media
Photo by VIRGINIA KAKLAMANI (@VKaklamani)Photo by VIRGINIA KAKLAMANI (@VKaklamani)Photo by VIRGINIA KAKLAMANI (@VKaklamani)Photo by VIRGINIA KAKLAMANI (@VKaklamani)Photo by VIRGINIA KAKLAMANI (@VKaklamani)Photo by VIRGINIA KAKLAMANI (@VKaklamani)Photo by VIRGINIA KAKLAMANI (@VKaklamani)Photo by VIRGINIA KAKLAMANI (@VKaklamani)Photo by VIRGINIA KAKLAMANI (@VKaklamani)Photo by VIRGINIA KAKLAMANI (@VKaklamani)
VIRGINIA KAKLAMANI retweeted
Neil Vasan (@NeilVasan) profile picture
Neil Vasan
@NeilVasanOct 28
I am proud to support @DrDawnHershman @columbiacancer for @ASCO Board of Directors. Her research has transformed how we care for patients with breast cancer, and she is Co-Chair of @SWOG. She is the most generous mentor I know and will represent us well. Please vote. Vision and video here - asco.org/about-asco/asco-ove…
Image from Neil Vasan (@NeilVasan)
3
18
895
Fantastic data by @drsarahsam in #BRIDGET showing the activity of #tucatinib in pts with 🧠 mets....used in combo w/ standard therapies..building upon what we saw in HER2CLIMB. ⬆️ unmet need! #ESMO26 #ESMOAmbassadors @OncoAlert
ESMO - Eur. Oncology (@myESMO) profile pictureESMO - Eur. Oncology
@myESMOOct 26
#ESMO26: Practice-changing improvement in intracranial progression-free survival seen with the addition of tucatinib to standard therapy in HER2-positive metastatic #BreastCancer (#MBC) in the BRIDGET #ClinicalTrial. Read more ow.ly/Gc4550ZZO6K #InsightsbyESMO
Image from ESMO - Eur. Oncology (@myESMO)
11
24
1,551
My #esmo26 breast summary: atirmo great data await phase 3; datodxd active in cns; pembro active in pdl1 >10 er+; Chinese “me too” need h2h; same payload no benefit; add tucatinib to delay cns progression; adj cdk os benefit (attn to stats) but giredestrant better tolerability.
1
15
1
43
3,743
VIRGINIA KAKLAMANI retweeted
Primum (@PrimumHealthInc) profile picture
Primum
@PrimumHealthIncOct 25
More familiar faces at #ESMO2026! Wonderful to catch up with Primum breast cancer experts Dr. Virginia Kaklamani (@VKaklamani), @DrReshmaMahtani, and Dr. Alberto Montero. We're grateful for their dedication to sharing expertise and helping fellow oncologists navigate challenging clinical decisions. #BreastCancer #Primum #ESMO2026
Image from Primum (@PrimumHealthInc)
Image from Primum (@PrimumHealthInc)
Image from Primum (@PrimumHealthInc)
2
3
208
Best part of any meeting is the post meeting discussion is data while enjoying the local cuisine @hmcarthur @KateIdaLathrop #esmo2026
Image from VIRGINIA KAKLAMANI (@VKaklamani)
4
48
1,425
VIRGINIA KAKLAMANI retweeted
Hope Rugo (@hoperugo) profile picture
Hope Rugo@hoperugoOct 24
Replying to @RebeccaDSing
@RebeccaDSing presents efficacy of Dato-Dxd in patients with TNBC on TB02. In the small subset with BMs Dato DXd improved CNS response and PFS! Nice data immediately applicable to clinical practice. @myesmo #ESMO2026 @OncoAlert
Image from Hope Rugo (@hoperugo)
Image from Hope Rugo (@hoperugo)
Image from Hope Rugo (@hoperugo)
Image from Hope Rugo (@hoperugo)
21
41
1,947
Looking forward to an amazing #ESMO26 @KateIdaLathrop @mayscancer
Image from VIRGINIA KAKLAMANI (@VKaklamani)
2
1
44
781
Excited to take part in a virtual Project ECHO® series on personalized strategies for patients with HR+/HER2– breast cancer, from early-stage to advanced disease. Submit a case for discussion, and see the details below: tinyurl.com/ynh2bwzv
Project ECHO®: Advancing Personalized Care Across the HR+/HER2– Breast Cancer Continuum | PER

Project ECHO®: Advancing Personalized Care Across the HR+/HER2– Breast Cancer Continuum | PER

Webinar Series

gotoper.com
1
4
6
571
VIRGINIA KAKLAMANI retweeted
OncUpdates (@OncUpdates) profile picture
OncUpdates
@OncUpdatesOct 19
⭐️ Ep. 1: Tissue vs Liquid Biopsy Testing in HR+ mBC 🎙️ @OncBrothers + @VKaklamani @KalinskyKevin @DrWGradishar & Dr. Nazarullah discuss when and how to use tissue vs ctDNA in HR+/HER2− metastatic breast cancer. #bcsm #BreastCancer #OncTwitter 🎥 👇 oncupdates.com/video-podcast…
Tissue vs. Liquid Biopsy Testing in HR+ mBC - OncUpdates

Tissue vs. Liquid Biopsy Testing in HR+ mBC - OncUpdates

Alia Nazarulla, MD; Kevin Kalinsky, MD, MS, FASCO; and Virginia Kaklamani, MD, DSc, discuss tissue and liquid biopsy testing in metastatic breast cancer.

oncupdates.com
6
7
688
Important to follow the data and not the pictures and our bias.
Harold J. Burstein, MD, PhD, FASCO (@DrHBurstein) profile pictureHarold J. Burstein, MD, PhD, FASCO
@DrHBursteinOct 15
This is an important article. A US-based, randomized study shows no benefit to focal ablation of asymptomatic metastatic disease in advanced breast cancer. Such approaches should not be considered standard of care.
3
10
1,210
VIRGINIA KAKLAMANI retweeted
Colton Jones (@theglpman) profile picture
Colton Jones@theglpmanOct 12
Youngest Recipient of the Order of Distinction National Awards for the Commonwealth of The Bahamas 2026! A big thank you to my family, friends, mentors and colleagues for the support throughout the years! @VisitTheBahamas @LSOM_HemOnc @mayscancer @UTHealthSA @HonPhilipEDavis @oncodaily @VJOncology @VJHemOnc @hemeoncfellow – at Cuba
Image from Colton Jones (@theglpman)
Image from Colton Jones (@theglpman)
Image from Colton Jones (@theglpman)
3
1
11
348
VIRGINIA KAKLAMANI retweeted
Sukeshi Arora MD (@DrSukeshiArora) profile picture
Sukeshi Arora MD@DrSukeshiAroraOct 8
#SALCS26 kicking off today. @UTHealthSA @mayscancer @UnivTransplant @UTHealthGME @UTSA #livercancer
Image from Sukeshi Arora MD (@DrSukeshiArora)
Image from Sukeshi Arora MD (@DrSukeshiArora)
7
12
703
#HER2CLIMB05 regimen now @FDA approved for 1st line #HER2 #bcsm maintenance! Amazing to now have a maintenence option for patients that have HR- tumors as well! pfizer.com/news/press-releas… @OncBrothers @oncodaily @OncoAlert @SarahCannonDocs
5
15
3
57
9,192
His contributions have revolutionized breast cancer treatment.
SABCS (@SABCSSanAntonio) profile pictureSABCS@SABCSSanAntonioOct 6
Charles M. Perou, PhD, will receive the 2026 William L. McGuire Memorial Lecture Award at #SABCS26 in recognition of his pioneering research in cancer genomics and breast cancer biology. He will deliver his award lecture on Thursday, Dec. 10, at 9 AM CT. bit.ly/4j8Xd70
Image from SABCS (@SABCSSanAntonio)
Image from SABCS (@SABCSSanAntonio)
9
17
1,132
Honored to be the Grand Rounds Speaker for the Dr. Teresa Flippo Morton Memorial Lecture Series at the @LevineCancer. Enjoyed my interactions with everyone. Thanks for having me @atanmdlci @MSKCancerCenter @MSK_DeptOfMed
Image from Komal Jhaveri, MD, FACP, FASCO (@jhaveri_komal)
Image from Komal Jhaveri, MD, FACP, FASCO (@jhaveri_komal)
3
5
38
2,401
Please consider registering for this meeting: bit.ly/47D0OTA

Project ECHO®: From Recurrence Risk to Treatment Choice: Leveraging Genomic and Clinical Data in...

HR+/HER2– breast cancer remains the most common breast cancer subtype, and clinicians increasingly face complex decisions in both the early-stage and advanced disease settings. In early-stage...

registration.gotoper.com
1
4
693
Can we spare CDK4/6i in ER+ early breast cancer and escalate only when needed? #AFT70 NAVIGATE: giredestrant + serial MRD monitoring, with CDK4/6i added only if MRD turns +ve. 2,000+ pts, ~200 sites. Risk-adapted, not one-size-fits-all. @guptalabunc @MSKCancerCenter @OncoAlert
Alliance for Clinical Trials in Oncology (@ALLIANCE_org) profile pictureAlliance for Clinical Trials in Oncology@ALLIANCE_orgOct 5
Alliance Foundation Trials and Natera have launched AFT-70 NAVIGATE, a global Phase III trial in ER+/HER2- early-stage breast cancer, evaluating giredestrant, Genentech’s investigational oral SERD, with Signatera™ MRD-guided CDK4/6 inhibitor therapy: bit.ly/4rKzlbQ
Image from Alliance for Clinical Trials in Oncology (@ALLIANCE_org)
2
20
1
55
3,379
VIRGINIA KAKLAMANI retweeted
Sara Tolaney (@stolaney1) profile picture
Sara Tolaney@stolaney1Oct 3
Replying to @AnnPartridgeMD
@AnnPartridgeMD gives a phenomenal keynote as the Lynn Sage Distinguished Lecture - what an incredible set of work that has impacted so many of our patients with young onset breast cancer @lynnsage
Image from Sara Tolaney (@stolaney1)
Image from Sara Tolaney (@stolaney1)
Image from Sara Tolaney (@stolaney1)
Image from Sara Tolaney (@stolaney1)
1
13
46
2,165
VIRGINIA KAKLAMANI retweeted
Oncology Brothers (@OncBrothers) profile picture
Oncology Brothers
@OncBrothersOct 2
Are you going to be at #SABCS26? Let’s talk through current SoC & how #SABCS26 will change this! InPerson: Dec 9, 2026 w/ @sdent_cardioonc @hoperugo @ErikaHamilton9 @PTarantinoMD @hmcarthur & DrSaraHurvitz Register: bit.ly/aiosabcs26 #AdvInOnc26 #OncTwitter @OncoAlert
Image from Oncology Brothers (@OncBrothers)
14
3
28
6,640
What comes next for your patients with HR+/HER2– metastatic breast cancer after progression on a CDK4/6 inhibitor? We'll be reviewing the latest oral SERD data and case-based treatment decisions in San Antonio this December. Join us! bit.ly/4xWtnpQ

Breast Cancer Symposia in San Antonio

registration.gotoper.com
1
7
31
2,635
Load more